Skip to main content
SpringerLink
Log in

Selektive interne Radiotherapie

  • Chapter
  • First Online:
Angiofibel

  • 4052 Accesses

Zusammenfassung

Indiziert ist die selektive interne Radiotherapie (SIRT) zur Palliativbehandlung primärer und sekundärer Lebertumoren, wenn:

  • die Haupttumormasse auf die Leber beschränkt

  • eine operative oder lokal ablative Therapie (z. B. Radiofrequenzablation) nicht durchführbar ist

  • die Standard-Chemotherapie zu keinem Tumoransprechen führte oder aufgrund ausgeprägter Nebenwirkungen abgesetzt wurde

Von Studienergebnissen wird abhängen, welchen Stellenwert die SIRT künftig in der stadiengerechten Erstlinientherapie ausgewählter Tumorentitäten haben kann. Bis dahin erfolgt die Indikationsstellung patientenindividuell im interdisziplinären Tumorboard. Wichtig für die Durchführung einer SIRT sind ein guter Allgemeinzustand des Patienten und eine gute Leberfunktion.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 159.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  1. Bilbao JI, Reiser MF (2008) Liver Radioembolization with 90Y Microspheres. 90Y Microspheres: Concepts and Principles. Springer Verlag, Berlin, Heidelberg, New York, S. S7

    Book  Google Scholar 

  2. Covey AM, Brody LA, Maluccio MA, Brown Covey KTA, Getrajdman GI et al (2002) Variant hepatic arterial anatomy revisited: digital subtraction angiography performed in 600 patients. Radiology 224:542–547

    Article  PubMed  Google Scholar 

  3. Iñarrairaegui M, Martinez-Cuesta A, Rodríguez M, Bilbao JI, Arbizu J, Benito A, Sangro B, D’Avola D, Herrero JI, Quiroga J, Prieto J, Alegre F et al (2010) Analysis of prognostic factors after yttrium-90 radioembolization of advanced hepatocellular carcinoma. Int J Radiation Oncology Biol Phys 77:1441–1448

    Article  Google Scholar 

  4. Kennedy AS, Dezarn WA, McNeillie P, Coldwell D, Nutting C, Carter D, Murthy R, Salem R, Rose S, Warner RR, Liu D, Palmedo H, Overton C, Jones B, Kennedy A et al (2008) Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: early results in 148 patients. Am J Clin Oncol 31:271–279

    Article  PubMed  Google Scholar 

  5. Kulik LM, Carr BI, Mulcahy MF, Lewandowski RJ, Atassi B, Ryu RK, Sato KT, Benson 3rd A, Kulik LM, Nemcek Jr AA, Gates VL, Abecassis M, Omary RA, Salem R et al (2008) Safety and efficacy of 90Y radiotherapy for hepatiocellular carcinoma with and without portal vein thrombosis. Hepatology 47:71–81

    Article  PubMed  Google Scholar 

  6. Liu DM, Salem R, Bui JT, Courtney A, Barakat O, Sergie Z, Atassi B, Wong CY, Gowland P, Oman B, Lewandowski RJ, Gates VL, Thurston KG, Barrett K et al (2005) Angiographic considerations in patients undergoing liver-directed therapy. J Vasc Interv Radiol 16:911–935

    Article  PubMed  Google Scholar 

  7. Memon K, Lewandowski RJ, Mulcahy MF, Riaz A, Ryu RK, Sato KT, Gupta R, Nikolaidis P, Miller FH, Yaghmai V, Gates VL, Atassi B, Newman S, Omary RA, Benson 3rd AB, Salem R (2012) Radioembolization for neuroendocrine liver metastases: safety, imaging, and long-term outcomes. Int J Radiat Oncol Biol Phys 83:887–894

    Article  PubMed  Google Scholar 

  8. Salem R, Lewandowski RJ, Mulcahy MF, Riaz A, Ryu RK, Ibrahim S, Atassi B, Baker T, Gates V, Miller FH, Sato KT, Wang E, Gupta R, Benson AB, Newman SB, Omary RA, Abecassis M, Kulik L (2010) Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report pf long-term outcomes. Gastroenterology 138:52–64

    Article  PubMed  CAS  Google Scholar 

  9. Sangro B, Salem R, Kennedy A, Coldwell D, Wasan H (2011) Radioembolization for hepatocellular carcinoma: a review of the evidence and treatment recommendations. Am J Clin Oncol 34:422–431

    Article  PubMed  Google Scholar 

  10. Sangro B, Carpanese L, Cianni R, Golfieri R, Gasparini D, Ezziddin S, Paprottka PM, Fiore F, Van Buskirk M, Bilbao JI, Ettorre GM, Salvatori R, Giampalma E, Geatti O, Wilhelm K, Hoffmann RT, Izzo F, Iñarrairaegui M, Maini CL, Urigo C, Cappelli A, Vit A, Ahmadzadehfar H, Jakobs TF, Lastoria S (2011) Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation. Hepatology 54:868–878

    Article  PubMed  Google Scholar 

  11. Saxena A, Chua TC, Bester L, Kokandi A, Morris DL (2010) Factors predicting response and survival after yttrium-90 radioembolization of unresectable neuroendocrine tumor liver metastases: a critical appraisal of 48 cases. Ann Surg 251:910–916

    Article  PubMed  Google Scholar 

  12. Seidensticker R, Denecke T, Kraus P, Seidensticker M, Mohnike K, Fahlke J, Kettner E, Hildebrandt B, Dudeck O, Pech M, Amthauer H, Ricke J (2012) Matched-pair comparison of radioembolization plus best supportive care versus best supportive care alone for chemotherapy refractory liver-dominant colorectal metastases. Cardiovasc Intervent Radiol 35:1066–1073

    Article  PubMed  Google Scholar 

  13. Van Hazel G, Blackwell A, Anderson J, Price D, Moroz P, Bower G, Cardaci G, Gray B (2004) Randomnized phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer. J Surg Oncol 88:78–85

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Abteilung für Diagnostische und Interventionelle Radiologie, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 110, 69120, Heidelberg, Deutschland

    Ulrike Stampfl PD Dr. med.

  2. Radiologische Klinik und Poliklinik, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Deutschland

    Clemens Kratochwil Dr. med.

Authors
  1. Ulrike Stampfl PD Dr. med.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Clemens Kratochwil Dr. med.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ulrike Stampfl PD Dr. med. .

Editor information

Editors and Affiliations

  1. Radiologische Klinik, Abteilung Diagnostische und Intervention, Universität Heidelberg, Im Neuenheimer Feld 110, Heidelberg, 69120, Baden-Württemberg, Germany

    Boris A. Radeleff

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Stampfl, U., Kratochwil, C. (2013). Selektive interne Radiotherapie. In: Radeleff, B. (eds) Angiofibel. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-33230-2_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-33230-2_14

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-33229-6

  • Online ISBN: 978-3-642-33230-2

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation